Back
Viking Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
VKTX
Viking Therapeutics
Last Price:
$22.63
Seasonality Move:
9.94%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.84 | Sell |
20-day SMA: | 27.42 | Sell |
50-day SMA: | 29.64 | Sell |
200-day SMA: | 49.18 | Sell |
8-day EMA: | 24.92 | Sell |
20-day EMA: | 26.76 | Sell |
50-day EMA: | 30.63 | Sell |
200-day EMA: | 42.93 | Sell |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.79 | Sell |
Relative Strength Index (14 RSI): | 33.56 | Sell |
Chaikin Money Flow: | 154565 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.3 - 29.72) | Sell |
Bollinger Bands (100): | (27.53 - 49.47) | Sell |
Viking Therapeutics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 22.62 while VKTX 8-day simple moving average is 24.84, which is a Sell signal.
-
The stock price of VKTX is 22.62 while Viking Therapeutics 20-day SMA is 27.42, which makes it a Sell.
-
Viking Therapeutics 50-day simple moving average is 29.64 while VKTX share price is 22.62, making it a Sell technically.
-
VKTX stock price is 22.62 and Viking Therapeutics 200-day simple moving average is 49.18, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
24
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a SellThe current Viking Therapeutics [VKTX] share price is $22.62. The Score for VKTX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
2.5B
Price in USD:
22.62
Share Volume:
6.6M
Viking Therapeutics 52-Week Range
52-Week High:
81.86
52-Week Low:
21.53
Sell
24
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 22.62 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 22.62 while VKTX 8-day exponential moving average is 24.92, which is a Sell signal.
-
The stock price of VKTX is 22.62 while Viking Therapeutics 20-day EMA is 26.76, which makes it a Sell.
-
Viking Therapeutics 50-day exponential moving average is 30.63 while VKTX share price is 22.62, making it a Sell technically.
-
VKTX stock price is 22.62 and Viking Therapeutics 200-day simple moving average is 42.93, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.57 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is -1.79, suggesting Viking Therapeutics is a Sell
-
Viking Therapeutics Relative Strength Index (RSI) is 33.56, which suggest Viking Therapeutics is oversold
-
The Bollinger Bands (25) for Viking Therapeutics is (25.3 - 29.72), which suggest Viking Therapeutics is a Sell
-
The Bollinger Bands (100) for Viking Therapeutics is (27.53 - 49.47), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.